CD8A and liver cancer: In vivo experiments, To substantiate the LPS-RGD-Nb36-DOX+ activated CD8+ T cells treatment in attacking tumor cells within vivo, a mouse subcutaneous transplanted tumor model of liver cancer and lung cancer, as well as a PDX model about primary liver cancer, were constructed.